Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2019 Jul 16;18(3):700–709.e3. doi: 10.1016/j.cgh.2019.07.018

Figure 2c:

Figure 2c:

Prior Treatment History and Course of Patients with Nucleos(t)ide analogue-related HBsAg loss. Prior NA treatment indicated by yellow bar, an asterisk and a double cross; prior interferon treatment indicated by purple bar. Green bar indicates period of HBsAg positivity since initial visit. Black bar indicates time of HBsAg loss. Red bar indicates duration of follow-up after HBsAg loss.